Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001 The IND is a comprehensive dossier of information, including animal and human studies, pharmacokinetic analyses, toxicology studies,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Neurizon Files IND Application to Support HEALEY ALS Platform Trial )
Also on site :
- Vacaville carjacking suspects arrested in Fairfield; suspect shot by police
- ForexLive Asia-Pacific FX news wrap: Oil spike on talk of Israel preparing attack on Iran
- On the record: Hubbard